Given Imaging (GIVN) Announces Litigation Settlement with Olympus; Will Revise FY08 Earnings
More News related to GIVN
- Oscar Gruss Upgrades Given Imaging Ltd. (GIVN) to Buy
- Given Imaging to Present at the Needham & Company Biotechnology and Medical Technology Conference
- New Clinical Study Shows Over Half of Eligible OGIB Patients May Benefit From Small Bowel Capsule Endoscopy as Recommended by GI Society Guidelines
- Study Concludes PillCam ESO(R) Correlates Well With EGD in Detecting and Grading Esophageal Varices -- A Potentially Lethal Complication of Advanced Liver Disease
- Study Confirms Given Imaging's Bravo(R) pH Monitoring System to Be a Very Effective Diagnostic Tool for Assessing GERD
Given Imaging Ltd. (Nasdaq: GIVN) has signed the final settlement agreement with Olympus Corporation ending the patent litigation between the parties.
The Company is analyzing the applicable tax, if any, on the payment of $2.33 million to the Company, and will revise its 2008 fiscal year earnings per share guidance together with the release of the results of the second quarter of 2008.
Given Imaging Ltd. develops, manufactures and markets diagnostic products for the visualization and detection of disorders of the gastrointestinal tract. [SM]
Related Categories
Corporate NewsGuidance
Stocks Mentioned
-0.53Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
